Bilingual Customer Service Representative
About the job
- Previous customer service experience, preferably in healthcare or insurance.
- Strong verbal and written communication skills.
- Independent decision-making and problem-solving skills, with the ability to remain calm under pressure.
- Ability to handle high volumes of calls, chats, and emails effectively.
- Proficiency in computer applications, including customer relationship management (CRM) and customer support platforms.
- Ability to work flexible shifts, including weekends and holidays.
- Must be 18 years or older.
- High school diploma or equivalent.
- Must be fluent in English.
- Must be fluent in Spanish.
- Must reside in the State of New Mexico.
- Provide guidance on provider networks, referrals, and pre-authorizations.
- Troubleshoot and resolve issues related to billing, payments, and coverage.
- Ensure compliance with HIPAA regulations when handling sensitive member information.
- Collaborate with internal departments to resolve complex member concerns.
- Maintain accurate records of customer interactions and resolutions in CRM systems.
- Meet performance metrics such as response time, resolution rate, and customer satisfaction scores.
- Stay updated on policies, state regulations, and healthcare industry changes.
- Assist members with inquiries related to health insurance coverage, claims, benefits, and provider networks via phone, email, and chat.
About the company
Ibex Biosciences focuses on discovering, validating, and producing biotechnology solutions for health and ecological challenges. Its product portfolio includes therapeutic antibodies, gene therapy, and stem cell programs, as well as diagnostic antibodies for Immunohistochemistry (IHC) to improve biopsy accuracy. The company advances its products by conducting exploratory R&D on projects that may not yet be validated in public research, then develops and commercializes these technologies through licensing, partnerships, and direct sales to healthcare and research institutions. A key differentiator is Ibex’s diversified, internally driven pipeline and its mix of therapeutics and diagnostics, alongside active engagement in grant funding and patenting. The company’s goal is to bring proprietary biotech innovations to market to enhance patient outcomes and health-related research, addressing significant cancer-related and other health challenges.
Company Size
1-10
Company Stage
Early VC
Total Funding
$4.2M
Headquarters
North Bethesda, Maryland
Founded
2015
Get referred to IBEX
See people who can refer or advise you
Simplify's Take
What believers are saying
- Ibex keeps an open 506(c) offering, signaling active capital formation in 2026.
- The 2022 CD147 patent supports oncology and inflammation licensing conversations.
- Anti-MIF VHH development continues, with animal-model testing already disclosed.
What critics are saying
- Ibex has no disclosed commercial products, leaving revenue dependent on financing.
- The open Regulation D offering implies dilution risk and financing pressure through 2026.
- Without clinical validation, the company risks becoming a perpetual patent shop.
What makes IBEX unique
- North Bethesda-based Ibex Biosciences focuses on antibody, gene-therapy, and stem-cell programs.
- Its 2026 pipeline spans CD147 antibodies, anti-MIF VHHs, and PCBP1 stem-cell methods.
- Ibex still controls early patentable assets, including 2022 CD147 publication.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Performance Bonus